FDA’s Section 804 Prescription Drug Importation Program and 801(d)(1)(B) Guidance

Published date14 January 2020
AuthorKevin Madagan, Cori Annapolen Goldberg and Catherine David,Kevin Madagan, Cori Annapolen Goldberg, Sung Park and Catherine David
Subject MatterFood, Drug & Agriculture,Health Care
Law FirmReed Smith LLP

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT